| Bria Alexander, OTR/L | |
|
926 Main St, Nashville, TN 37206-3614 | |
| (888) 605-9060 | |
| Not Available |
| Full Name | Bria Alexander |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 926 Main St, Nashville, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073192191 | NPI | - | NPPES |
| 118777 | Other | TX | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 118777 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bria Alexander, OTR/L 926 Main St, Nashville, TN 37206-3614 Ph: (888) 605-9060 | Bria Alexander, OTR/L 926 Main St, Nashville, TN 37206-3614 Ph: (888) 605-9060 |
News Archive
Gary Popiel had to drive more than 200 miles round trip to visit his adult daughters in separate behavioral health facilities as they received psychiatric and medical treatment.
Two weeks after filing for a union election among 46,000 Kaiser workers in California, the National Union of Healthcare Workers (NUHW) refused to sign an agreement that would allow the election to go forward in the next 60 days.
A mother's nurture may provide powerful protection against risks her baby faces in the womb, according to a new article published online today in the journal Biological Psychiatry. The research shows that fetuses exposed to high levels of stress hormone - shown to be a harbinger for babies' poor cognitive development - can escape this fate if their mothers provide them sensitive care during infancy and toddler-hood.
Titan Pharmaceuticals, Inc. today announced the initiation of a randomized, placebo and active controlled, multi-center Phase 3 clinical study of Probuphine in the treatment of opioid addiction. This confirmatory Phase 3 study will be conducted at approximately 23 sites in the United States and randomize approximately 250 patients into three arms: Probuphine (100 patients), Suboxone® (100 patients) and placebo (50 patients).
› Verified 8 days ago
Kathleen Alice Pittman, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5505 Edmonson Pike, Ste 103, Nashville, TN 37211 Phone: 615-831-1710 | |
Mr. Kyle Thomas Emerson, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 301 21st Ave N, Nashville, TN 37203 Phone: 615-329-6600 | |
Mrs. Jill Story Roberts, OTD, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3305 W End Ave, Nashville, TN 37203 Phone: 615-386-4900 | |
Linda T Twelves, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 329 Murfreesboro Rd, Nashville, TN 37210 Phone: 615-244-6900 | |
Andrea Morrissey I, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4511 Georgia Ave, Nashville, TN 37209 Phone: 978-857-3825 | |
Danyele Clingan, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 Metroplex Dr Ste 308, Nashville, TN 37211 Phone: 615-614-8833 | |
Makenzie Ann Holtermann, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 Metroplex Drive, Suite 308, Nashville, TN 37211 Phone: 615-614-8833 |